Gencurix Past Earnings Performance

Past criteria checks 0/6

Gencurix's earnings have been declining at an average annual rate of -32.4%, while the Medical Equipment industry saw earnings growing at 18.7% annually. Revenues have been growing at an average rate of 19.8% per year.

Key information

-32.4%

Earnings growth rate

-25.2%

EPS growth rate

Medical Equipment Industry Growth22.7%
Revenue growth rate19.8%
Return on equity-156.0%
Net Margin-369.8%
Last Earnings Update30 Sep 2024

Recent past performance updates

Gencurix (KOSDAQ:229000) Is Posting Healthy Earnings, But It Is Not All Good News

Mar 28
Gencurix (KOSDAQ:229000) Is Posting Healthy Earnings, But It Is Not All Good News

Recent updates

Gencurix (KOSDAQ:229000) Is Posting Healthy Earnings, But It Is Not All Good News

Mar 28
Gencurix (KOSDAQ:229000) Is Posting Healthy Earnings, But It Is Not All Good News

Revenue & Expenses Breakdown

How Gencurix makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

KOSDAQ:A229000 Revenue, expenses and earnings (KRW Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 243,394-12,5487,6314,333
30 Jun 242,914-14,2477,7954,292
31 Mar 242,897-16,3578,3784,379
31 Dec 232,600-19,2608,1734,529
30 Sep 232,700-19,4378,2924,769
30 Jun 232,222-20,4668,1994,750
31 Mar 232,212-24,2397,9354,734
31 Dec 222,559-24,5977,6624,181
30 Sep 223,492-30,8287,4923,827
30 Jun 223,700-34,3616,9583,782
31 Mar 223,464-17,4756,0003,597
31 Dec 213,047-34,6705,8453,475
30 Sep 212,13310,7515,3403,715
30 Jun 211,67819,8155,0613,502
31 Mar 211,80112,3204,8333,378
31 Dec 201,57233,1084,6403,154
30 Sep 20816-7,3354,1922,892
31 Dec 19137-9,1623,9281,811

Quality Earnings: A229000 is currently unprofitable.

Growing Profit Margin: A229000 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: A229000 is unprofitable, and losses have increased over the past 5 years at a rate of 32.4% per year.

Accelerating Growth: Unable to compare A229000's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: A229000 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-13.3%).


Return on Equity

High ROE: A229000 has a negative Return on Equity (-156.04%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 14:49
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Gencurix Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution